Patient Opportunity Equity Strategy’s Q4 2024 Investor Letter
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter.
Hedge Fund - Patient Capital Management
News, Interviews, and Investor Letters
- First
- << Previous
- 31 - 40
- Next >>
Will QXO (QXO) Become a Long-Term Compounder?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should you Hold Precigen (PGEN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Patient Capital Management Exited Everi Holdings (EVRI) After Acquisition Announcement
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Patient Capital Management Saw Kosmos Energy (KOS) as a Classic Case Of Time Arbitrage
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Will Energy Transfer (ET) Offer Attractive Pricing Opportunities in Long-Term?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Invest in Dave & Buster’s Entertainment (PLAY)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Alibaba Group Holdings (BABA) Rebounded and Gained 47% in Q3
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Patient Capital Management: “Seadrill Limited (SDRL) Could Either Consolidate The Space Or Be Acquired”
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Expedia Group (EXPE) Bounced Back in Q3
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
- First
- << Previous
- 31 - 40
- Next >>